Score Overview
Explore the 2021 public Archive ranking →
Where NeoGenomics Inc has ranked, year by year
Showing 10 years ranking history by HDB Score.
Has not reached the top 50 on HDB Score in any year we have ranked.
- NEO
2011: 71.1% · 2021: 28.4% · free through 2021 · longest runs
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-09-28 | $ 19.29 | — |
1 Year2025-09-26 | $ 7.93 | 143.25% |
5 Years2021-09-28 | $ 46.26 | -58.30% |
10 Years2016-09-28 | $ 8.02 | 140.58% |
20 Years2006-09-28 | $ 0.99 | 19x |
| Period | Last Price2026-09-28 | 1 Year2025-09-26 | 5 Years2021-09-28 | 10 Years2016-09-28 | 20 Years2006-09-28 |
|---|---|---|---|---|---|
| Price | $ 19.29 | $ 7.93 | $ 46.26 | $ 8.02 | $ 0.99 |
| Return | — | 143.25% | -58.30% | 140.58% | 19x |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 766M | -$ 51M | $ 145M |
| 2025 | $ 727M | -$ 108M | $ 159M |
| 2024 | $ 660M | -$ 78M | $ 386M |
| 2023 | $ 591M | -$ 87M | $ 415M |
| 2022 | $ 509M | -$ 144M | $ 437M |
| 2021 | $ 484M | -$ 8M | $ 515M |
| 2020 | $ 444M | $ 4M | $ 296M |
| 2019 | $ 408M | $ 8M | $ 173M |
| 2018 | $ 276M | $ 2M | $ 9M |
| 2017 | $ 240M | -$ 396K | $ 12M |
| 2016 | $ 244M | -$ 6M | $ 12M |
| 2015 | $ 99M | -$ 2M | $ 23M |
| 2014 | $ 87M | $ 1M | $ 33M |
| 2013 | $ 66M | $ 2M | $ 4M |
| 2012 | $ 59M | $ 65K | $ 1M |
| 2011 | $ 43M | -$ 1M | $ 2M |
| 2010 | $ 34M | -$ 3M | $ 1M |
| 2009 | $ 29M | -$ 2M | $ 1M |
| 2008 | $ 20M | -$ 1M | $ 468.17K |
| 2007 | $ 11M | -$ 3M | $ 210.57K |
| 2006 | $ 6M | -$ 130K | $ 126.27K |
| 2005 | $ 1M | -$ 997K | $ 10.94K |
| 2004 | $ 558.07K | -$ 819K | $ 112.55K |
| 2003 | $ 369.97K | -$ 536K | $ 25.05K |
| 2002 | $ 93.49K | -$ 590.52K | |
| 2001 | -$ 8M | $ 77.22K | |
| 2000 | $ 252.4K | -$ 970K | $ 186.00 |
NeoGenomics Inc fundamental performance
Between 2020 and 2025, revenue grew from $ 444M to $ 727M and net income went from $ 4M to -$ 108M. Revenue increased in every one of those 5 years; net income in 3.
Across NeoGenomics Inc's full reported history, from 2000 to 2025, revenue grew from $ 252.4K to $ 727M and net income went from -$ 970K to -$ 108M. Revenue increased in 96% of the years measured; net income in 50%.
NeoGenomics Inc currently holds a 20-year HDB Score of 4.2 out of 10. How the HDB Score is calculated.
Membership
Continue NEO’s history
The public Archive runs through 2021. Membership adds recent and current rankings.
- Recent and current rankings across 3,816 companies
- Compare companies with the latest data
- Track your research shortlist in a portfolio
